Acadia Healthcare Company, Inc. $ACHC Stock Position Boosted by Prescott Group Capital Management L.L.C.

Prescott Group Capital Management L.L.C. boosted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 40.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 70,000 shares of the company’s stock after purchasing an additional 20,000 shares during the quarter. Prescott Group Capital Management L.L.C.’s holdings in Acadia Healthcare were worth $1,925,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Acadia Healthcare during the second quarter valued at approximately $441,685,000. Jefferies Financial Group Inc. purchased a new stake in shares of Acadia Healthcare during the second quarter valued at $106,458,000. First Trust Advisors LP boosted its position in shares of Acadia Healthcare by 73.0% during the first quarter. First Trust Advisors LP now owns 1,689,442 shares of the company’s stock valued at $39,516,000 after buying an additional 712,852 shares during the last quarter. Deutsche Bank AG purchased a new stake in shares of Acadia Healthcare during the second quarter valued at $49,746,000. Finally, Maverick Capital Ltd. increased its holdings in Acadia Healthcare by 45.1% in the 1st quarter. Maverick Capital Ltd. now owns 1,314,116 shares of the company’s stock worth $30,737,000 after buying an additional 408,697 shares in the last quarter.

Acadia Healthcare Price Performance

ACHC stock opened at $29.62 on Wednesday. The company has a market cap of $2.76 billion, a price-to-earnings ratio of -2.38, a P/E/G ratio of 9.54 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The business’s 50-day moving average is $29.14 and its two-hundred day moving average is $25.81. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.

Wall Street Analysts Forecast Growth

ACHC has been the subject of a number of recent analyst reports. Raymond James Financial lowered Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 target price for the company. in a research report on Monday, September 28th. TD Cowen raised their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. KeyCorp lifted their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. UBS Group boosted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Finally, Barclays increased their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research report on Thursday, July 30th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $30.69.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.